Skip to content
MS
Sign in
Single-pathway Pathway metabolite unreviewed

Nascent VLDL

0
Pathways
0
Categories
0
As substrate
0
As product
What can this become? Show on map

Reactions involving Nascent VLDL

Every recorded step where this molecule takes part

All 2 Consumed 1 Produced 1

Showing all 2 reactions.

Recent literature

Refresh

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Lipid Metabolic Reprogramming and Bioactive Lipid Signaling in MASLD: Molecular Mechanisms, Pathogenesis and Therapeutic Opportunities.

    Ábel T, Csobod Csajbókné É. · 2026-08-31

    open access unreviewed
  2. 2
    Targeting hepatic cholesterol sensing to tackle metabolic dysfunction-associated steatohepatitis.

    Zang M, Li Y. · 2026-07-15

    open access unreviewed
  3. 3
    SEC16B identified as a regulator of VLDL secretion and lipid accumulation in the liver.

    Ardehali H. · 2026-07-15

    open access unreviewed
  4. 4
    Hepatic SEC16B regulates lipid homeostasis by coordinating VLDL secretion and lipid droplet expansion.

    Lu W, Zhao Z, Molina D, Fan H, Shi R, Tian Y, Gopoju R, Yang T, Zhang X, Zhang Y, Zhang K, Amengual J, Wang B. · 2026-04-24

    cited 1× open access unreviewed
  5. 5
    Hepatic Lipoprotein Production, Cardiometabolic Phenotypes, and Subtypes of Steatotic Liver Disease.

    Davidson NO. · 2026-06-04

    cited 1× unreviewed
  6. 6
    Exogenous Ganglioside GM3 Attenuates Atherosclerosis via Multi-Organ Modulation of Lipid Metabolism.

    Zhou J, Zhuang H, Sheng Q, Qiu Z, Chen Y. · 2026-04-29

    open access unreviewed
  7. 7
    VLDLR: A Multifunctional receptor in diverse pathophysiological processes.

    Wang X, Chen Y, Wei J, Li Y, Xu J, Dai T, Tang N, Han C, Zhou Y. · 2026-03-26

    open access unreviewed
  8. 8
    Seipin expression in hepatocytes impairs the assembly of VLDLs and exacerbates steatohepatitis.

    Dong Q, Ma Y, Chen X, Wang X, Liu Z, Liang C, Qiu L, Tang J, Wu J, Liu Y, Wu X, Zhou Y, Gao M, Yang H. · 2026-01-29

    cited 2× open access unreviewed
  9. 9
    MAFLD: a ferroptotic disease.

    Cui S, Ye J. · 2025-09-09

    cited 9× unreviewed
  10. 10
    A narrative review of impacts of apolipoproteins on atherosclerotic coronary plaques.

    Fukase T, Dohi T. · 2026-02-02

    cited 1× open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.